Comparison of five experimental pain tests to measure analgesic effects ofalfentanil

Citation
M. Luginbuhl et al., Comparison of five experimental pain tests to measure analgesic effects ofalfentanil, ANESTHESIOL, 95(1), 2001, pp. 22-29
Citations number
43
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANESTHESIOLOGY
ISSN journal
00033022 → ACNP
Volume
95
Issue
1
Year of publication
2001
Pages
22 - 29
Database
ISI
SICI code
0003-3022(200107)95:1<22:COFEPT>2.0.ZU;2-6
Abstract
Background: Several experimental pain models have been used to measure opio id effects in humans. The aim of the current study was to compare the quali ties of five frequently used experimental pain tests to measure opioid effe cts. Methods: The increase of electrical, heat, and pressure pain tolerance and the decrease of ice-water and ischemic pain perception was determined at ba seline and at four different plasma concentrations of alfentanil (n = 7) ad ministered as target controlled infusion or placebo (n = 7). A linear mixed -effects modeling (NONMEM) was performed to detect drug, placebo, and time effect as well as interindividual and intraindividual variation of effect. Results: Only the electrical, ice-water, and pressure pain tests are sensit ive to assess a concentration-response curve of alfentanil. At a plasma alf entanil concentration of 100 ng/ml, the increase in pain tolerance compared with baseline was 42.0% for electrical pain, 22.2% for pressure pain, and 21.7% for Ice-water pain. The slope of the linear concentration-response cu rve had an interindividual coefficient of variation of 58.3% in electrical pain, 35.6% in pressure pain, and 60.0% in ice-water pain. The residual err or including intraindividual variation at an alfentanil concentration of 10 0 ng/ml was 19.4% for electrical pain, 6.1% for pressure pain, and 13.0% fo r ice-water pain. Electrical pain was affected by a significant placebo eff ect, and pressure pain was affected by a significant time effect. Conclusion: Electrical, pressure, and ice-water pain, but not ischemic and heat pain, provide significant concentration-response curves in the clinica lly relevant range of 200 ng/ml alfentanil or lower. The power to detect a clinically relevant shift of the curve is similar in the three tests. The a ppropriate test(s) for pharmacodynamic studies should be chosen according t o the investigated drug(s) and the study design.